A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.

The Department of Psychiatry and Behavioral Sciences ranked ninth in the country for NIH funding in 2023.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.

Is there a role for e-cigarettes among adults who have not been able to stop using combustible cigarettes after using FDA-approved medication?

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Three MUSC occupational therapy students are passionate about elevating the profession's role in cancer care.